Earnings per Share (EPS) (Basic): A company's net earnings or losses attributable to common shareholders per basic share basis.
Cocrystal Pharma, Inc. (COCP) had Earnings per Share (EPS) (Basic) of $-0.19 for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-2.05M |
|
-- |
|
-- |
|
$2.09M |
|
$-2.09M |
|
$0.04M |
|
$-2.05M |
|
$-2.05M |
|
$-2.05M |
|
$-2.05M |
|
$-2.05M |
|
$-2.05M |
|
$-2.09M |
|
$-2.00M |
|
10.99M |
|
10.99M |
|
|
Earnings per Share (EPS) (Basic) |
$-0.19 |
$-0.19 |
|
| Balance Sheet Financials | |
$8.78M |
|
$0.11M |
|
$1.66M |
|
$10.45M |
|
$1.52M |
|
-- |
|
$1.26M |
|
$2.78M |
|
$7.67M |
|
$7.67M |
|
$7.67M |
|
13.04M |
|
| Cash Flow Statement Financials | |
$-6.46M |
|
$-0.01M |
|
$4.34M |
|
$9.94M |
|
$7.80M |
|
$-2.13M |
|
$0.21M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.78 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-6.47M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-26.72% |
|
-26.72% |
|
-19.62% |
|
-26.72% |
|
$0.59 |
|
$-0.59 |
|
$-0.59 |
|